Kodiak Sciences Announces Second Quarter 2020 Financial Results and Recent Business Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Kodiak Sciences Inc. (KOD) Tops Q2 EPS by 8c
August 10, 2020 5:54 AM EDTKodiak Sciences Inc. (NASDAQ: KOD) reported Q2 EPS of ($0.58), $0.08 better than the analyst estimate of ($0.66).
"We have made strong progress across the entire company this quarter clinical, manufacturing, research and corporate. I am very proud of how our growing Kodiak community has continued to execute in the midst of the ongoing global pandemic," said Victor Perlroth, MD, Chief Executive Officer of Kodiak. "There is a high unmet need for a new foundational therapy in the diseases we are exploring with KSI-301, namely wet age-related macular degeneration (wet AMD), diabetic macular edema (DME) and retinal... More
